Tyra Biosciences (TYRA) Depreciation & Amortization (CF) (2020 - 2026)
Quarterly Depreciation & Amortization (CF) fell 3.5% to $138000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $541000.0 through Mar 2026, changed 0.19% year-over-year, with the annual reading at $546000.0 for FY2025, 5.2% up from the prior year.
Tyra Biosciences filings provide 7 years of Depreciation & Amortization (CF) readings, the most recent being $138000.0 for Q1 2026.
- Depreciation & Amortization (CF) hit $138000.0 in Q1 2026 for Tyra Biosciences, up from $132000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $144000.0 in Q4 2024 and bottomed at $64000.0 in Q1 2022.
- Average Depreciation & Amortization (CF) over 5 years is $109176.5, with a median of $122000.0 recorded in 2024.
- The largest annual shift saw Depreciation & Amortization (CF) soared 190.91% in 2022 before it fell 8.33% in 2025.
- Tyra Biosciences' Depreciation & Amortization (CF) stood at $82000.0 in 2022, then increased by 24.39% to $102000.0 in 2023, then skyrocketed by 41.18% to $144000.0 in 2024, then dropped by 8.33% to $132000.0 in 2025, then rose by 4.55% to $138000.0 in 2026.
- Per Business Quant, the three most recent readings for TYRA's Depreciation & Amortization (CF) are $138000.0 (Q1 2026), $132000.0 (Q4 2025), and $131000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 123.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138,000.00 |
| Mar 31, 2026 | 138,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 144,000.00 |
| Dec 31, 2024 | 144,000.00 |
| Sep 30, 2024 | 127,000.00 |
| Sep 30, 2024 | 127,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Mar 31, 2023 | 83,000.00 |
| Mar 31, 2023 | 83,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | 82,000.00 |
| Sep 30, 2022 | 82,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Dec 31, 2020 | 19,000.00 |
| Dec 31, 2020 | 19,000.00 |
| Sep 30, 2020 | 16.00 Mn |
| Sep 30, 2020 | 16.00 Mn |